Unlocking the full potential of CAR-T cell therapies remains one of the most exciting and actively pursued frontiers in cancer research today. While the emergence of these innovative therapies has ...

“This milestone represents a pivotal step forward in our mission to develop transformative therapies for patients with difficult-to-treat diseases,” said Nicholas Siciliano, Ph.D., CEO of ...

“This milestone represents a pivotal step forward in our mission to develop transformative therapies for patients with difficult-to-treat diseases,” said Nicholas Siciliano, Ph.D., Chief ...